Outcome of 82 chronic myeloid leukemia patients treated with nilotinib or dasatinib after failure of two prior tyrosine kinase inhibitors

There have been few reports of a response to dasatinib or nilotinib after failure of two prior sequential tyrosine kinase inhibitors. We report the outcome of 82 chronic phase patients who received nilotinib or dasatinib as third-line alternative tyrosine kinase inhibitor therapy. Thirty-four patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rossi, Antonella Russo, Breccia, Massimo, Abruzzese, Elisabetta, Castagnetti, Fausto, Luciano, Luigiana, Gozzini, Antonella, Annunziata, Mario, Martino, Bruno, Stagno, Fabio, Cavazzini, Francesco, Tiribelli, Mario, Visani, Giuseppe, Pregno, Patrizia, Musto, Pellegrino, Fava, Carmen, Sgherza, Nicola, Albano, Francesco, Rosti, Gianantonio, Alimena, Giuliana, Specchia, Giorgina
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2013
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3659922/
https://ncbi.nlm.nih.gov/pubmed/22801965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.064337
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados